|
1
|
DeSantis C, Ma J, Bryan L and Jemal A:
Breast cancer statistics, 2013. CA Cancer J Clin. 64:52–62. 2014.
View Article : Google Scholar
|
|
2
|
Chen W, Chen W, Zheng R, Baade PD, Zhang
S, Zeng H, Bray F, Jemal A, Yu XQ and He J: Cancer statistics in
China, 2015. CA Cancer J Clin. 66:115–132. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Siegel RL, Miller KD and Jemal A: Cancer
statistics, 2016. CA Cancer J Clin. 66:7–30. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Samuel SM, Varghese E, Varghese S and
Büsselberg D: Challenges and perspectives in the treatment of
diabetes associated breast cancer. Cancer Treat Rev. 70:98–111.
2018. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Malhotra A, Jain M, Prakash H, Vasquez KM
and Jain A: The regulatory roles of long non-coding RNAs in the
development of chemoresistance in breast cancer. Oncotarget.
8:110671–110684. 2017. View Article : Google Scholar
|
|
6
|
Mercer TR, Dinger ME and Mattick JS: Long
non-coding RNAs: Insights into functions. Nat Revi Genet.
10:155–159. 2009. View
Article : Google Scholar
|
|
7
|
Costa FF: Non-coding RNAs: New players in
eukaryotic biology. Gene. 357:83–94. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Shi XF, Sun M, Liu H, Yao Y and Song Y:
Long non-coding RNAs: A new frontier in the study of human
diseases. Cancer Lett. 339:159–166. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Zhang Z, Li Z, Li Y and Zang A: MicroRNA
and signaling pathways in gastric cancer. Cancer Gene Ther.
21:305–316. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Gibb EA, Vucic EA, Enfield KS, Stewart GL,
Lonergan KM, Kennett JY, Becker-Santos DD, MacAulay CE, Lam S,
Brown CJ and Lam WL: Human cancer long non-coding RNA
transcrip-tomes. PLoS One. 6:e259152011. View Article : Google Scholar
|
|
11
|
Ke H, Zhao L, Feng X, Xu H, Zou L, Yang Q,
Su X, Peng L and Jiao B: NEAT1 is required for survival of breast
cancer cells through FUS and miR-548. Gene Regul Syst Bio. 10(Suppl
1): S11–S17. 2016.
|
|
12
|
Jiang X, Zhou Y, Sun AJ and Xue JL: NEAT1
contributes to breast cancer progression through modulating miR-448
and ZEB1. J Cell Physiol. 233:8558–8566. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Clemson CM, Hutchinson JN, Sara SA,
Ensminger AW, Fox AH, Chess A and Lawrence JB: An architectural
role for a nuclear noncoding RNA: NEAT1 RNA is essential for the
structure of paraspeckles. Mol Cell. 33:717–726. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Souquere S, Beauclair G, Harper F, Fox A
and Pierron G: Highly ordered spatial organization of the
structural long noncoding NEAT1 RNAs within paraspeckle nuclear
bodies. Mol Biol Cell. 21:4020–4027. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Iseli C, Stevenson BJ, de Souza SJ, Samaia
HB, Camargo AA, Buetow KH, Strausberg RL, Simpson AJ, Bucher P and
Jongeneel CV: Long-range heterogeneity at the 3′ends of human
mRNAs. Genome Res. 12:1068–1074. 2002. View
Article : Google Scholar : PubMed/NCBI
|
|
16
|
Chen LL and Carmichael GG: Gene regulation
by SINES and inosines Biological consequences of A-to-I editing of
Alu element inverted repeats. Cell Cycle. 7:3294–3301. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Choudhry H, Schödel J, Oikonomopoulos S,
Camps C, Grampp S, Harris AL, Ratcliffe PJ, Ragoussis J and Mole
DR: Extensive regulation of the non-coding transcriptome by
hypoxia: Role of HIF in releasing paused RNApol2. EMBO Rep.
15:70–76. 2014. View Article : Google Scholar :
|
|
18
|
Choudhry H, Albukhari A, Morotti M, Haider
S, Moralli D, Smythies J, Schödel J, Green CM, Camps C, Buffa F, et
al: Tumor hypoxia induces nuclear paraspeckle formation through
HIF-2α dependent transcriptional activation of NEAT1 leading to
cancer cell survival. 34:pp. 4482–4490. 2015
|
|
19
|
Curtis C, Shah SP, Chin SF, Turashvili G,
Rueda OM, Dunning MJ, Speed D, Lynch AG, Samarajiwa S, Yuan Y, et
al: The genomic and transcriptomic architecture of 2,000 breast
tumours reveals novel subgroups. Nature. 486:346–352. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Yang XL, Xiao Z, Du X, Huang L and Du G:
Silencing of the long non-coding RNA NEAT1 suppresses glioma
stem-like properties through modulation of the miR-107/CDK6
pathway. Oncol Rep. 37:555–562. 2017. View Article : Google Scholar
|
|
21
|
Wan P, Wu T, Zhou H, Jin Q, He G, Yu H,
Xuan L, Wang X, Tian L, Sun Y, et al: Long noncoding RNA NEAT1
promotes laryngeal squamous cell cancer through regulating
miR-107/CDK6 pathway. J Exp Clin Cancer Res. 35:222016. View Article : Google Scholar
|
|
22
|
Lee KH, Lotterman C, Karikari C, Omura N,
Feldmann G, Habbe N, Goggins MG, Mendell JT and Maitra A:
Epigenetic silencing of MicroRNA miR-107 regulates cyclin-dependent
kinase 6 expression in pancreatic cancer. Pancreatology. 9:293–301.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Davidson LA, Wang N, Shah MS, Lupton JR,
Ivanov I and Chapkin RS: n-3 Polyunsaturated fatty acids modulate
carcinogen-directed non-coding microRNA signatures in rat colon.
Carcinogenesis. 30:2077–2084. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Li XY, Luo QF, Wei CK, Li DF, Li J and
Fang L: MiRNA-107 inhibits proliferation and migration by targeting
CDK8 in breast cancer. Int J Clin Exp Med. 7:32–40. 2014.PubMed/NCBI
|
|
25
|
Fritz IB and Yue KT: Long-chain carnitine
acyltransferase and the role of acylcarnitine derivatives in the
catalytic increase of fatty acid oxidation induced by carnitine. J
Lipid Res. 4:279–288. 1963.PubMed/NCBI
|
|
26
|
Britton CH, Schultz RA, Zhang B, Esser V,
Foster DW and McGarry JD: Human liver mitochondrial carnitine
palmitoyltransferase I: Characterization of its cDNA and
chromosomal localization and partial analysis of the gene. Proc
Natl Acad Sci USA. 92:1984–1988. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
McGarry JD and Brown NF: The mitochondrial
carnitine palmitoyltransferase system. From concept to molecular
analysis. Eur J Biochem. 244:1–14. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Swierczynski J, Hebanowska A and
Sledzinski T: Role of abnormal lipid metabolism in development,
progression, diagnosis and therapy of pancreatic cancer. World J
Gastroenterol. 20:2279–2303. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Kroemer G and Pouyssegur J: Tumor cell
metabolism: cancer's Achilles' heel. Cancer Cell. 13:472–482. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Lin H, Lu JP, Laflamme P, Qiao S, Shayegan
B, Bryskin I, Monardo L, Wilson BC, Singh G and Pinthus JH:
Inter-related in vitro effects of androgens, fatty acids and
oxidative stress in prostate cancer: A mechanistic model supporting
prevention strategies. Int J Oncol. 37:761–766. 2010.PubMed/NCBI
|
|
31
|
Pucci S, Zonetti MJ, Fisco T, Polidoro C,
Bocchinfuso G, Palleschi A, Novelli G, Spagnoli LG and Mazzarelli
P: Carnitine palmitoyl transferase-1A (CPT1A): A new tumor specific
target in human breast cancer. Oncotarget. 7:19982–19996. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Trajkovski M, Hausser J, Soutschek J, Bhat
B, Akin A, Zavolan M, Heim MH and Stoffel M: MicroRNAs 103 and 107
regulate insulin sensitivity. Nature. 474:649–653. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Bhatia H, Pattnaik BR and Datta M:
Inhibition of mitochondrial β-oxidation by miR-107 promotes hepatic
lipid accumulation and impairs glucose tolerance in vivo. Int J
Obes (Lond). 40:861–869. 2016. View Article : Google Scholar
|
|
34
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar
|
|
35
|
Caley DP, Pink RC, Trujillano D and Carter
DR: Long noncoding RNAs, chromatin, and development. Scientific
World Journal. 10:90–102. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Gibb EA, Enfield KS, Stewart GL, Lonergan
KM, Chari R, Ng RT, Zhang L, MacAulay CE, Rosin MP and Lam WL: Long
non-coding RNAs are expressed in oral mucosa and altered in oral
premalignant lesions. Oral Oncol. 47:1055–1061. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Guo S, Chen W, Luo Y, Ren F, Zhong T, Rong
M, Dang Y, Feng Z and Chen G: Clinical implication of long
non-coding RNA NEAT1 expression in hepatocellular carcinoma
patients. Int J Clin Exp Pathol. 8:5395–5402. 2015.PubMed/NCBI
|
|
38
|
Chakravarty D, Sboner A, Nair SS,
Giannopoulou E, Li R, Hennig S, Mosquera JM, Pauwels J, Park K,
Kossai M, et al: The oestrogen receptor alpha-regulated lncRNA
NEAT1 is a critical modulator of prostate cancer. Nat Commun.
5:53832014. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Linher-Melville K, Zantinge S, Sanli T,
Gerstein H, Tsakiridis T and Singh G: Establishing a relationship
between prolactin and altered fatty acid β-Oxidation via carnitine
palmitoyl transferase 1 in breast cancer cells. BMC Cancer.
11:562011. View Article : Google Scholar
|
|
40
|
Mishra S, Yadav T and Rani V: Exploring
miRNA based approaches in cancer diagnostics and therapeutics. Crit
Rev Oncol Hematol. 98:12–23. 2016. View Article : Google Scholar
|
|
41
|
Wu Q, Guo L, Jiang F, Li L, Li Z and Chen
F: Analysis of the miRNA-mRNA-lncRNA networks in ER plus and
ER-breast cancer cell lines. J Cell Mol Med. 19:2874–2887. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Ye S, Yang L, Zhao X, Song W, Wang W and
Zheng S: Bioinformatics method to predict two regulation mechanism:
TF-miRNA-mRNA and lncRNA-miRNA-mRNA in Pancreatic Cancer. Cell
Biochem Biophys. 70:1849–1858. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Chiyomaru T, Fukuhara S, Saini S, Majid S,
Deng G, Shahryari V, Chang I, Tanaka Y, Enokida H, Nakagawa M, et
al: Long Non-coding RNA HOTAIR is targeted and regulated by miR-141
in human cancer cells. J Biol Chem. 289:12550–12565. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Braconi C, Kogure T, Valeri N, Huang N,
Nuovo G, Costinean S, Negrini M, Miotto E, Croce CM and Patel T:
microRNA-29 can regulate expression of the long non-coding RNA gene
MEG3 in hepatocellular cancer. Oncogene. 30:4750–4756. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Faghihi MA, Modarresi F, Khalil AM, Wood
DE, Sahagan BG, Morgan TE, Finch CE, St Laurent G III, Kenny PJ and
Wahlestedt C: Expression of a noncoding RNA is elevated in
Alzheimer's disease and drives rapid feed-forward regulation of
beta-secretase. Nat Med. 14:723–730. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Salmena L, Poliseno L, Tay Y, Kats L and
Pandolfi PP: A ceRNA Hypothesis: The Rosetta stone of a hidden RNA
language? Cell. 146:353–358. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Keniry A, Oxley D, Monnier P, Kyba M,
Dandolo L, Smits G and Reik W: The H19 lincRNA is a developmental
reservoir of miR-675 that suppresses growth and lgf1r. Nat Cell
Biol. 14:659–665. 2012. View Article : Google Scholar : PubMed/NCBI
|
